A Closer Look at the Remaining Uninsured Population Eligible for Medicaid and CHIP March 15, 2024 Issue Brief This issue brief examines the characteristics of the remaining uninsured population who are eligible for Medicaid or CHIP using 2022 national survey data. Despite improvements in coverage, 25.6 million nonelderly people remained uninsured in 2022.
Nearly a Quarter of People Who Say They Were Disenrolled from Medicaid During the Unwinding Are Now Uninsured April 12, 2024 News Release Nearly a quarter (23%) of adults who say they were disenrolled from Medicaid since early 2023 report being uninsured now, finds a new KFF national survey examining how the unwinding affected enrollees. Overall, 19% of adults who had Medicaid prior to the start of unwinding say they were disenrolled at…
10 Key Facts About Women with Medicare April 30, 2024 Issue Brief This brief examines 10 key facts about women with Medicare and presents new statistics on the health, economic and functional status of women with Medicare.
Key Data on Health and Health Care by Race and Ethnicity June 11, 2024 Page This analysis examines how people of color fare compared to White people across 64 measures of health, health care, and social determinants of health using the most recent data available from federal surveys and administrative sets as well as the 2023 KFF Survey on Racism, Discrimination, and Health.
How Many Uninsured Are in the Coverage Gap and How Many Could be Eligible if All States Adopted the Medicaid Expansion? February 26, 2024 Issue Brief Ten years after the implementation of the Affordable Care Act’s (ACA) coverage options, ten states have not adopted the Medicaid expansion, leaving 1.5 million uninsured people without an affordable coverage option. States that have not implemented the expansion have uninsured rates that are nearly double the rate of expansion states (14.1% compared to 7.5%).
3 Charts: The Cost and Coverage of Opill—the First FDA-approved Over-the-Counter Daily Oral Contraceptive Pill in the United States March 5, 2024 News Release The first FDA-approved over-the-counter daily oral contraceptive pill in the United States— Perrigo’s Opill— is now available for pre-order at major online retailers and will soon be available in stores. Although the new over-the-counter pill could broaden access to contraceptive options in the United States, KFF research suggests consumers are…
Oral Contraceptive Pills: Access and Availability March 20, 2024 Issue Brief This brief provides an overview of oral contraception, discusses private insurance and Medicaid coverage, and reviews strategies to promote and expand women’s access to oral contraceptives.
Three Questions About Medicaid Unwinding: What We Know and What to Expect February 28, 2024 Blog Ten months into the unwinding of the Medicaid continuous enrollment provision, states have conducted renewals for roughly half of all enrollees in the program. This policy watch examines three key questions to monitor as unwinding continues.
It’s Not a Health Care Election, But Health Issues Might Still Add Up February 28, 2024 From Drew Altman In this column, KFF President and CEO Drew Altman explores the potential for some health care issues—including abortion, drug costs and other affordability challenges—to influence enough voters in swing states to make a difference in this year’s presidential election.
SCOTUS Case Could Weaken the Impact of Regulation on Key Patient and Consumer Protections April 9, 2024 Issue Brief This brief discusses the longstanding legal doctrine, Chevron deference, being challenged in two cases before the U.S. Supreme Court and includes examples of what could be at stake for health care consumers should federal courts no longer use this doctrine to address litigation related to federal health regulations. The focus here is on patient and consumer protection regulation, but overturning the Chevron deference would have implications in all areas of health care.